300294 博雅生物
按盤價 
30.330 -0.820 (-2.632%)
30.330 -0.820 (-2.632%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.539 | 3.274 | 6.168 | 6.300 | 6.486 |
| 總資產報酬率 ROA (%) | 5.163 | 2.994 | 5.522 | 5.392 | 4.994 |
| 投入資產回報率 ROIC (%) | 5.448 | 3.233 | 6.081 | 6.013 | 5.686 | 邊際利潤分析 |
| 銷售毛利率 (%) | 66.666 | 52.758 | 54.657 | 56.982 | 58.074 |
| 營業利潤率 (%) | 38.575 | 13.395 | 19.291 | 16.716 | 13.189 |
| 息稅前利潤/營業總收入 (%) | 36.698 | 12.188 | 18.368 | 15.941 | 13.417 |
| 淨利潤/營業總收入 (%) | 33.124 | 9.357 | 16.148 | 13.517 | 10.953 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 81.526 | 159.564 | 100.786 | 108.372 | 91.941 |
| 價值變動淨收益/利潤總額(%) | 14.285 | 28.201 | 8.240 | 9.729 | 3.091 |
| 營業外收支淨額/利潤總額(%) | 0.025 | -0.428 | -0.034 | 0.014 | -1.013 | 償債能力分析 |
| 流動比率 (X) | 12.010 | 14.082 | 8.611 | 8.948 | 3.358 |
| 速動比率 (X) | 10.866 | 12.862 | 7.665 | 7.876 | 2.567 |
| 資產負債率 (%) | 7.060 | 6.490 | 9.316 | 9.201 | 0.187 |
| 帶息債務/全部投入資本 (%) | 1.693 | 0.830 | 0.708 | 0.819 | 8.373 |
| 股東權益/帶息債務 (%) | 5,787.189 | 11,905.027 | 13,936.386 | 12,032.500 | 1,083.961 |
| 股東權益/負債合計 (%) | 1,316.259 | 1,440.684 | 960.198 | 973.774 | 425.214 |
| 利息保障倍數 (X) | -19.450 | -10.600 | -20.046 | -20.505 | 37.259 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 54.532 | 45.580 | 59.165 | 60.914 | 72.950 |
| 存貨周轉天數 (天) | 385.280 | 175.840 | 193.372 | 215.694 | 223.947 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/11/2024 14:05 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
